Free AI scores & summaries library
Health Care · Biotechnology
Market cap divided by sales over the last 12 months. Useful for companies that aren’t profitable yet.
Latest P/S Ratio
9759.70x
As of Dec 30, 2024
Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/S Ratio |
|---|---|
| Dec 30, 2024 | 9759.70x |
| Dec 27, 2024 | 9994.81x |
| Dec 26, 2024 | 10238.98x |
| Dec 24, 2024 | 10035.51x |
| Dec 23, 2024 | 9931.51x |
| Dec 20, 2024 | 9960.90x |
| Dec 19, 2024 | 9786.82x |
| Dec 18, 2024 | 9714.48x |
P/S Ratio = Market Capitalization / Revenue (TTM)
P/S ignores profitability and capital structure, making it a simple but blunt valuation tool.
Read the general P/S Ratio definition, formula, and analyst usage guide.
P/S Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison